Specialist Updates 
Rheumatology

Diabetes drug class may reduce gout risk

Large study of patients with diabetes demonstrates uric acid reduction
Reuters Health
0
14 January 2020
Save
ClosePlease login
Gout

Treatment with an SGLT-2 inhibitor may protect against gout in adults with type 2 diabetes, research suggests.

US researchers drew on a nationwide commercial insurance database to compare a cohort of 119,530 patients newly prescribed an SGLT-2 inhibitor with a similar number newly prescribed a GLP-1 receptor agonist, with mean follow-up of 302 days and 261 days, respectively.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .